Oncology

From outpatient care facilities and specialty clinics to infusion centers and research labs, here are 32 health systems opening cancer centers or expanding oncology services in 2026:

David Strickland has been named regional CIO of Duarte, Calif.-based City of Hope. Mr. Strickland previously worked at Oakland, Calif.-based Kaiser Permanente for nearly 20 years, finishing his time there as vice president of product management and virtual care. He…

New Orleans-based LCMC Health has named Amelia Jernigan, MD, director of the cancer service line. Dr. Jernigan currently serves as medical director of cancer services at University Medical Center New Orleans for LCMC Health and is the Ronald D. Alvarez,…

Less than half of patients ages 65 and older with metastatic non-small cell lung cancer received systemic treatment, according to a study published May 7 in JAMA Oncology.  Researchers from Charleston-based Medical University of South Carolina, Memphis, Tenn.-based Baptist Cancer…

Daraxonrasib, a drug that targets the genetic driver of most pancreatic cancers, extended clinical trial participants’ progression-free survival by a median of 8.5 months, according to a study published May 6 in The New England Journal of Medicine.  Fifteen cancer…

Livonia, Mich.-based Trinity Health will invest $22.7 million in renovations at the Trinity Health Grand Rapids (Mich.) Richard J. Lacks Sr. Cancer Center. The cancer center will remain open during construction, which is expected to be completed in fall 2028,…

Wilmington, Del.-based ChristianaCare has appointed Deepak Vadehra, DO, chief of gastrointestinal oncology.  Dr. Vadehra shared news of his appointment in a May 6 LinkedIn post.  He was also appointed director of clinical trials and director of clinical research for solid…

Tampa, Fla.-based Moffitt Cancer Center recorded an operating income of $63.7 million (7.3% operating margin) during the third quarter of fiscal 2026, up from $40.2 million (5.2% margin) during the same period last year, according to its May 6 financial…

Researchers from Rochester, Minn.-based Mayo Clinic and Stanford (Calif.) Medicine have developed a blood test capable of mapping cancer cell ecosystems to predict immunotherapy response, according to a study published May 6 in Nature.  Certain cell ecosystems, or neighborhoods, are…

The FDA has approved a companion diagnostic from Guardant Health to identify patients eligible for treatment with a targeted therapy developed by Pfizer and Arvinas. The blood-based test detects ESR1 mutations in patients with estrogen receptor-positive, HER2-negative advanced or metastatic…